MEG3 is low expressed in NSCLC, and has an impact on the immunity and autophagy of NSCLC cells via regulating the miR-543/IDO signaling pathway, which is effective for the treatment of NSCLC. The gene discussed is IDO1; the disease is non-small cell lung carcinoma.